Morich Frank

Perspective Therapeutics, Inc. · Director

Morich Frank is listed in filings as Director at Perspective Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including 5 public disclosures. Recent filings connect the profile to Perspective Therapeutics, Inc. (CATX) and Cue Biopharma, Inc. (CUE). The current snapshot covers public activity from Jun 24, 2024 to Mar 4, 2026. Reported amounts are shown as $267.5K to $123.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.
Morich Frank History Trades | TradingNote